Cidara Therapeutics Inc (NASDAQ:CDTX)
| 0.55 Delayed Data As of Jun 24 |  -0.0349 / -6.29%Today’s Change | 0.40 Today|||52-Week Range 2.39 | -56.69% Year-to-Date |
Latest CDTX News | Press Releases
No recent news for Cidara Therapeutics Inc.
Today’s Trading
| Previous close | 0.55 |
| Today’s open | 0.60 |
| Day’s range | 0.52 - 0.63 |
| Volume | 473,416 |
| Average volume (3 months) | 284,790 |
| Market cap | $39.0M |
Data as of 3:57pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | +55.06% |
| Earnings growth (this year) | -39.26% |
| Earnings growth (next 5 years) | +47.10% |
| Revenue growth (last year) | +310.81% |
| P/E ratio | NM |
| Price/Sales | 1.34 |
| Price/Book | 1.78 |
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $49.6M |
| Annual profit (last year) | -$42.5M |
| Net profit margin | -85.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
